In 1Q16, LabCorp’s (LH) contract research organization (or CRO) business, Covance Drug Development, accounted for 30.7% of the company’s total revenues. Covance Drug Development accounted for about 24 ...

New Jersey-based drug development services company Covance Inc. (CVD) recently divested its antibody services unit to antibodies and reagents developer and manufacturer BioLegend, Inc. However, ...

PRINCETON, N.J., July 15 Covance Inc. (NYSE: CVD) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD).

Medical testing firm LabCorp (LH) plans to pay roughly $6.1 billion in cash and stock to buy medical research firm Covance (CVD) in a transaction aimed at creating a healthcare diagnostics giant, the ...

BURLINGTON, N.C.--(BUSINESS WIRE)--An independent report has established that physician clinical-trial investigators identify Covance Central Laboratory Services as their "most preferred" central ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Laboratory Corp of America Holdings (LH.N) said it would pay $6.1 billion (3.81 billion pounds) for Covance Inc (CVD.N ...

Covance (NYSE:CVD) hit a new 52-week high Wednesday as it is currently trading at $72.39, above its previous 52-week high of $72.10 with 3,091 shares traded as of 9:31 a.m. ET. Average volume has been ...

Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced its new brand, Solutions Made Real TM. This brand strategy more effectively articulates Covance's ...

Laboratory Corporation of America® Holdings (LabCorp®) and Covance Inc. have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued ...

Ford, Sapient and Covance are among stocks to watch. MarketWatch's Tomi Kilgore has the details on the News Hub with Simon Constable. Photo: Getty Laboratory Corp. of America Holdings, one of the ...